Identification of <i>N</i>,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase InhibitorMaria Gabriella Brasca, Marina Ciomei, Valter Croci et al.|Journal of Medicinal Chemistry|2009Cited by 128
Antitumor activity of edotecarin in breast carcinoma modelsMarina Ciomei, Enrico Pesenti, Valter Croci et al.|Cancer Chemotherapy and Pharmacology|2006Cited by 13
Abstract #3737: A highly potent, selective and orally available ALK inhibitor with demonstrated antitumor efficacy in ALK dependent lymphoma and non small cell lung cancer modelsElena Ardini, Arturo Galvani, Maria Menichincheri et al.|Cancer Research|2009Cited by 0
STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1-METHYL-4,5-DIHYDRO- 1H-PYRAZOLO[4,3-H] QUINAZOLINE-3-CARBOXYLIC ACIDMaria Gabriella Brasca, Marina Ciomei, Nadia Amboldi et al.|Unknown|2009Cited by 0